JPRN-UMIN000038748Completed未知
Effect of immunotherapy on oncological and patientst reported outcomes in patients with metastatic renal cell cancer - Effect of immunotherapy on oncological and patientst reported outcomes in patients with metastatic renal cell cancer
Dept. of Urology, Hirosaki University Graduate School of Medicine0 sites23 target enrollmentStarted: December 1, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 23
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 100years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •History of severe cardiac conditions, such as angina requiring certain treatment with nitrates, unstable angina defined for study, positive cardiac stress test before starting the study. History of significant central nervous system (CNS) injuries (including stroke or spinal cord injury) within 6 months of Visit 1. History of drug, alcohol, or substance abuse within the 6 months before Visit 1. Have any condition, limitation, or disease that could, in the judgment of the investigator, preclude evaluation of response to therapy and Qo
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effect of immunotherapy on oncological and patientst reported outcomes in patients with urothelial cancerrothelial carcinomaJPRN-UMIN000038747Hirosaki Univ.200
Active, not recruiting
Not Applicable
The influence of immunotherapy and chemotherapy accompanying endurance training on incidence and severity of cognitive deficits as well as other therapy-induced side effects and complications in oncological patients. A randomized controlled trialDIVERSEC00-C75Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissueDRKS00011390niversitäres Centrum für Tumorerkrankungen (UCT) FrankfurtKrankenhaus NordwestKlinik für Onkologie und Hämatologie2
Completed
Unknown
To evaluate effect of immunotherapy .CTRI/2024/02/062655HCG NCHRI Cancer Centre10
Active, not recruiting
Not Applicable
Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma - NDEUCTR2006-003746-42-ITOSPEDALE ONCOLOGICO DI BARI210
Not yet recruiting
Phase 3
The Effect of Immunonutrition and Chemotherapy Induced Neutropenia in Advanced Gastrointestinal Cancer Receiving Palliative Chemotherapy A Pilot Randomized Controlled TrialMalnutrition in Advanced Gastrointestinal Cancer Receiving Palliative Chemotherapyadvance gastrointestinal cancer, malnutritionTCTR20210723001Chulalongkorn university50